Authors
Zhen-Hao Zhang, Shu-Han Lan, Bin Li, Yan Qi, Zi-Qi Zhang, Qiong Yuan, Xing-Chun Gou
Published in
Talanta. Volume 313. Issue Pt A. Pages 130695. Sep 29, 2026. Epub Sep 29, 2026.
Abstract
5-Methylcytosine (5 mC) represents the most prevalent and functionally significant DNA modification in mammalian genomes. Aberrations in its status are intricately associated with the pathogenesis of various diseases, including cancer and neurodegenerative disorders. The ultrasensitive detection of low-abundance 5 mC in trace biological fluids, such as plasma, holds great potential for early disease diagnosis and may drive the evolution of clinical diagnostic methodologies. Therefore, we have developed a β-glucosyltransferase and Ten-eleven translocation (TET) dioxygenases-assisted pyridine borane conversion and click chemistry ligation-initiated flow cytometry assay (TAPβ-CCLFC) for site-specific 5 mC analysis. In this method, TAPβ conversion gently converts DNA epigenetic modifications into distinguishable base variations. Furthermore, a peptide nucleic acid (PNA) clamp acts synergistically with click chemistry to enable single-base discrimination and further improve assay specificity. Ligation products are efficiently enriched on magnetic nanobeads, followed by template-independent, primer-free isothermal amplification via terminal deoxynucleotidyl transferase (TdT) to achieve high sensitivity. Consequently, the TAPβ-CCLFC enables precise discrimination of 5 mC at a frequency as low as 1.4%, and achieves a detection limit as low as 1 fM. Its practical utility has been further validated using human plasma samples. Collectively, the TAPβ-CCLFC strategy provides a robust and convenient platform with a simplified workflow for the sensitive, specific, and quantitative detection of 5 mC.
PMID:
42826484
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0